ArticleCureus2026
Articular Manifestations in Inflammatory Bowel Disease: A Retrospective Study From a Moroccan Tertiary Care Center.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundArticular manifestations are among the most common extraintestinal manifestations of inflammatory bowel disease (IBD) and may precede, accompany, or follow intestinal symptoms. Their recognition is clinically important because delayed diagnosis can lead to functional impairment and structural damage.
methodsWe conducted a retrospective descriptive study in the Department of Hepato-Gastroenterology at Mohammed VI University Hospital, Marrakech, Morocco. Patients with confirmed IBD and associated rheumatologic manifestations who were followed between December 2023 and December 2024 were included. Epidemiological, clinical, biological, radiological, therapeutic, and outcome data were extracted from medical records and analyzed using Microsoft Excel 2019 (Microsoft Corporation, Redmond, USA).
resultsAmong 150 patients with IBD, 60 had articular manifestations, corresponding to a prevalence of 40%. Crohn disease (CD) was present in 33 patients (55%), ulcerative colitis (UC) in 24 patients (40%), and indeterminate colitis in three patients (5%). There was a female predominance, with 41 women (68.3%) and 19 men (31.7%). Articular symptoms occurred after the diagnosis of intestinal disease in 37 patients (61.7%), before it in 17 patients (28.3%), and concomitantly in six patients (10%). Mixed axial and peripheral involvement was the most frequent pattern, observed in 35 patients (58.3%), followed by isolated peripheral involvement in 16 patients (26.7%) and isolated axial involvement in nine patients (15%). Inflammatory back pain was reported in 44 patients (73.3%), buttock pain in 37 patients (61.7%), and radiographic sacroiliitis in 25 patients (41.7%). Human leukocyte antigen B27 (HLA-B27) was positive in three of 33 tested patients (9.1%).
conclusionsArticular manifestations were frequent in this Moroccan IBD cohort and were dominated by mixed axial and peripheral involvement. Systematic screening for musculoskeletal symptoms in patients with IBD and close collaboration between gastroenterologists and rheumatologists are essential for early diagnosis, optimized management, and prevention of functional impairment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.